Pharmacotherapy in early infantile autism
Insights
Drug treatment for early childhood psychoses can aid other therapies, but research is needed on psychoactive drug effects on cognition and development. More classification is required for effective treatment selection.
Area of Science:
- Childhood developmental disorders
- Psychopharmacology
- Neurodevelopmental disorders
Background:
- Drug treatment is a valuable component of managing early childhood psychoses.
- Effective medications can improve a child's receptiveness to other interventions like special education.
- Current knowledge gaps exist regarding the impact of psychoactive drugs on cognition, growth, and endocrine systems in this population.
Purpose of the Study:
- To review current drug treatments for psychoses in early childhood.
- To highlight the need for further research into the effects of psychoactive agents.
- To emphasize the necessity for improved classification systems in this field.
Main Methods:
- Review of existing literature on drug treatment for early childhood psychoses.
- Analysis of the current state of knowledge regarding the efficacy and side effects of psychotropic medications.
- Discussion of the limitations in understanding the impact of these drugs on cognitive and physiological development.
Main Results:
- Drug therapy is an essential part of the comprehensive treatment for early childhood psychoses.
- Psychoactive drugs primarily address symptoms rather than underlying diseases.
- There is a significant lack of data on the effects of these drugs on cognition, growth, weight, endocrine systems, and organs.
Conclusions:
- While beneficial, current drug treatments for early childhood psychoses target symptoms and require better classification.
- Further research is crucial to understand the full impact of psychoactive drugs on developing children.
- Integrating clinical distinctions with biochemical and physiological criteria may improve treatment prediction and efficacy.
Abstract:
An up-to-date review of drug treatment in psychoses of early childhood is presented. At the present time, of all biological interventions in these developmental disorders, drug treatment alone remains a valuable addition or an essential treatment modality of the total treatment. Experience has shown that a therapeutically effective potent drug can make the autistic child more amenable to other therapies, including special education. However, knowledge is lacking about the effect of various psychoactive agents on cognition in this patient population as well as their influence on growth, weight, endocrine systems, and organs. Drugs currently in use treat symptoms, not diseases. A great need for classification in this area persists. The same symptoms may be caused by a variety of etiologic factors, and autism may or may not be the earliest expression of childhood schizophrenia. It is suggested that clinical distinctions be correlated or even improved by certain biochemical, neuroendocrine, and physiological criteria; this also may be of considerable value in predicting whether a child can benefit from a specific drug.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Alzheimer's Disease: Treatment
Operant Conditioning Intervention
In operant conditioning, behaviors that are...
Drug Therapy
Antianxiety Medications
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.


